[HTML][HTML] Crosstalk between endoplasmic reticulum stress and oxidative stress: a dynamic duo in multiple myeloma
Under physiological and pathological conditions, cells activate the unfolded protein
response (UPR) to deal with the accumulation of unfolded or misfolded proteins in the …
response (UPR) to deal with the accumulation of unfolded or misfolded proteins in the …
[HTML][HTML] Mitochondrial bioenergetics at the onset of drug resistance in hematological malignancies: an overview
A Barbato, G Scandura, F Puglisi, D Cambria… - Frontiers in …, 2020 - frontiersin.org
The combined derangements in mitochondria network, function and dynamics can affect
metabolism and ATP production, redox homeostasis and apoptosis triggering, contributing …
metabolism and ATP production, redox homeostasis and apoptosis triggering, contributing …
[HTML][HTML] FOXM1 regulates glycolysis and energy production in multiple myeloma
The transcription factor, forkhead box M1 (FOXM1), has been implicated in the natural
history and outcome of newly diagnosed high-risk myeloma (HRMM) and relapsed/refractory …
history and outcome of newly diagnosed high-risk myeloma (HRMM) and relapsed/refractory …
LncRNA PDIA3P interacts with c-Myc to regulate cell proliferation via induction of pentose phosphate pathway in multiple myeloma
X Yang, H Ye, M He, X Zhou, N Sun, W Guo… - Biochemical and …, 2018 - Elsevier
Multiple myeloma (MM), the second most common hematologic malignancy, is an incurable
disease characterized by the accumulation of malignant plasma cells within the bone …
disease characterized by the accumulation of malignant plasma cells within the bone …
[HTML][HTML] ARK5 enhances cell survival associated with mitochondrial morphological dynamics from fusion to fission in human multiple myeloma cells
S Karnan, I Hanamura, A Ota, LQ Vu, K Uchino… - Cell Death …, 2024 - nature.com
Abstract 5′ adenosine monophosphate–activated protein kinase–related kinase 5 (ARK5)
is involved in mitochondrial ATP production and associated with poor prognosis of multiple …
is involved in mitochondrial ATP production and associated with poor prognosis of multiple …
[HTML][HTML] Iron regulates myeloma cell/macrophage interaction and drives resistance to bortezomib
G Camiolo, A Barbato, C Giallongo, N Vicario… - Redox Biology, 2020 - Elsevier
Iron plays a major role in multiple processes involved in cell homeostasis such as
metabolism, respiration and DNA synthesis. Cancer cells exhibit pronounced iron retention …
metabolism, respiration and DNA synthesis. Cancer cells exhibit pronounced iron retention …
[HTML][HTML] Inhibition of TLR4 signaling affects mitochondrial fitness and overcomes bortezomib resistance in myeloma plasma cells
Multiple myeloma (MM) is a B-cell malignancy requiring inflammatory microenvironment
signals for cell survival and proliferation. Despite improvements in pharmacological tools …
signals for cell survival and proliferation. Despite improvements in pharmacological tools …
[HTML][HTML] Mitochondrial metabolic determinants of multiple myeloma growth, survival, and therapy efficacy
Multiple myeloma (MM) is a plasma cell dyscrasia characterized by the clonal proliferation of
antibody producing plasma cells. Despite the use of next generation proteasome inhibitors …
antibody producing plasma cells. Despite the use of next generation proteasome inhibitors …
Lactate trafficking inhibition restores sensitivity to proteasome inhibitors and orchestrates immuno‐microenvironment in multiple myeloma
A Barbato, C Giallongo, S Giallongo… - Cell …, 2023 - Wiley Online Library
Metabolic changes of malignant plasma cells (PCs) and adaptation to tumour
microenvironment represent one of the hallmarks of multiple myeloma (MM). We previously …
microenvironment represent one of the hallmarks of multiple myeloma (MM). We previously …
[HTML][HTML] TLR4 signaling and heme oxygenase-1/carbon monoxide pathway crosstalk induces resiliency of myeloma plasma cells to bortezomib treatment
G Scandura, C Giallongo, F Puglisi, A Romano… - Antioxidants, 2022 - mdpi.com
Relapse in multiple myeloma (MM) decreases therapy efficiency through unclear
mechanisms of chemoresistance. Since our group previously demonstrated that heme …
mechanisms of chemoresistance. Since our group previously demonstrated that heme …